Harriet Ng'ombe,Samuel Bosomprah,Bernard Phiri,Mutinta Muchimba,Fraser Liswaniso,Mwelwa Chibuye,Charlie Chaluma Luchen,Kennedy Chibesa,Kalo Musukuma-Chifulo,Kapambwe Mwape,Sekayi Tigere,Suwilanji Silwamba,Annel Sinkala,Michelo Simuyandi,Nyuma Mbewe,Fred Kapaya,Adam F Cunningham,Roma Chilengi,David Sack,Caroline Cleopatra Chisenga

Abstract:Cholera is responsible for 1.3 to 4.0 million cholera cases globally and poses a significant threat, with Zambia reporting 17,169 cases as of 4th February 2024. Recognizing the crucial link between natural cholera infections and vaccine protection, this study aimed to assess immune responses post cholera infection and vaccination. This was a comparative study consisting of 50 participants enrolled during a cholera outbreak in Zambia's Eastern Province and an additional 56 participants who received oral cholera vaccinations in Zambia's Central Province. Vibriocidal antibodies were plotted as geometric mean titres in the naturally infected and vaccinated individuals. A significant difference (p < 0.047) emerged when comparing naturally infected to fully vaccinated individuals (2 doses) on day 28 against V. cholerae Ogawa. Those who received two doses of the oral cholera vaccine had higher antibody titres than those who were naturally infected. Notably, the lowest titres occurred between 0-9 days post onset, contrasting with peak responses at 10-19 days. This study addresses a critical knowledge gap in understanding cholera immunity dynamics, emphasizing the potential superiority of vaccination-induced immune responses. We recommend post infection vaccination after 40 days for sustained immunity and prolonged protection, especially in cholera hotspots.

Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia